Zykadia (ceritinib) tablets, 150mg (YJ code: 4291044F1022, standard: 150mg 1 tablet), manufactured by Novartis Pharma, are a kinase inhibitor used to treat adults with metastatic anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC). This medication works by blocking an abnormal protein that stimulates the growth of these cancer cells.
Zykadia tablets 150mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).